Changing Microbiology Of The Prosthetic Joint Infection And Updating Antibiotics Strategy

Yanjie Mao,Hao Shen,Jin Tang,Qiaojie Wang,Wanjun Liu,Wenqi Gu,Xianlong Zhang,Yao Jiang
2016-01-01
Abstract:Background: With the increasing number in total joint arthroplasty (TJA), prosthetic joint infection (PJI) is becoming difficult to treat. Although many efforts have been made to eradicate PJI, whether current treatments are sufficient is still unknown. Therefore by studying microbiology and their susceptibility to antibiotic agents, our purpose was to get better understanding of pathogenesis and provide advice to update strategies to prevent and treat PJI. Material and methods: A retrospective analysis of 126 patients diagnosed as PJI during 2003 and 2013 was performed. The microbiology and antibiotic susceptibility of PJI were studied. A theoretical model analysis was used to compare the susceptibilities of three most prophylactically used antibiotics and their dual combination. Results: Through the study period, coagulase-negative staphylococci (CoNS) was the most commonly isolated strain (35.4%). The rising numbers of CoNS and methicillin-resistant staphylococci were found through the study period. All gram-positive microorganisms were sensitive to vancomycin, teicoplanin and linezolid, while 16 of 51 (31.4%) aerobic gram-positive organisms were resistant to gentamicin, 33 of 58 (56.9%) gram-positive organisms were resistant to cefazolin. Gram-negative ones were all sensitive to amikacin, piperacillin-tazobactam, and carbapenem. Conclusion: The combination of vancomycin and gentamicin can be used prophylactically in bone cement for TKA and vancomycin and cefazolin can be used parenterally for cementless TJA to prevent PJI. The antibiotic can be used empirically depending on the classification of PJI before the final culture result is available, as well as vancomycin plus carbapenem in early and late infections, and vancomycin alone in delayed infection.
What problem does this paper attempt to address?